TAVR: Insights and Perspectives

By Ted E. Feldman, MD, MSCAI, FACC, FESC, and Bernard Prendergast, BMedSci, BM BS, MRCP, DM, FRCP, FESC

New Insights From the STS/ACC TVT Registry

What these ongoing data tell us about TAVR and future areas of interest.

By Frederick L. Grover, MD, and David R. Holmes Jr, MD

Making the Most of CT in TAVR Planning

From clinical research to standard-of-care procedural planning.

By Hasan Jilaihawi, MD

Echocardiographic Aortic Annulus Sizing for TAVR

Can it be done, and is this approach reliable and accurate?

By Nishath Quader, MD

Current TAVR Devices

Technical characteristics and evidence to date for FDA- and CE Mark-approved valves.

By Denise Todaro, MD; Andrea Picci, MD; and Marco Barbanti, MD

Aortic Valves: What's Coming?

Devices in early clinical development, including devices with early human experience and those originating from China.

By Thomas Modine, MD, PhD, MBA; Darren Mylotte, MD; and Nicolo Piazza, MD, PhD

The Equivalence of SAVR and TAVR

Potential pitfalls as the use of TAVR is extended to low- and intermediate-risk patients.

By Andrew Roy, MD, FESC; Dinesh Natarajan, MBBS, BMedSci; and Bernard Prendergast, BMedSci, BM BS, MRCP, DM, FRCP, FESC

Ask the Experts: What Is Your Institution's Approach to CAD in TAVR Patients?

Several institutions share their methods for treating patients with coronary artery disease who undergo transcatheter aortic valve replacement.

With Lowell Satler, MD; Toby Rogers, MD, PhD; Jubin Joseph, MA, BMBCh; Simon R. Redwood, MD; Giuliana Capretti, MD; Alaide Chieffo, MD; and Antonio Colombo, MD

Intra-Aortic Balloon Pump Counterpulsation: Old Friend or Foe?

The hemodynamics and utility of IABP counterpulsation in current practice.

By Lokien X. van Nunen, MD, PhD

Innovations

An Interview With Ralph Stephan von Bardeleben, MD

Dr. von Bardeleben provides insight into ongoing mitral valve trials and discusses use of mitral devices for tricuspid disease, as well as imaging protocols for transcatheter mitral valve interventions.